Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Cancer Research Technology Limited investment portfolio

Cancer Research Technology Limited has made numerous investments in companies such as Stratosvir, Storm Therapeutics, and Mosaic Therapeutics within the Biotech sector.

university
Portfolio
22
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (22)

CompanySectorCitySourceLast confirmed on
52 North Health LtdHealthcare & Life SciencesBarleythorpeConfirmed2026-02-21
Artios Pharma Limited
Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours.
Healthcare & Life SciencesCambridgeConfirmed2025-12-28

Sign up to see the full portfolio

+20 more companies

Sign up

Shareholding changes (13)

Cancer Research Technology Limited's positions across portfolio companies
2026
  • 06-11IncreasedTrogenix Ltd
    • SEED 3,500 → 7,750
    • SERIES A1 SHARES 0 → 4,411
  • 01-20ConvertedNeobe Therapeutics Ltd
    • A ORDINARY 8,696 → 0
    • ORDINARY 13,535 → 0
    • A ORDINARY 0.001 GBP 0 → 8,696
    • ORDINARY 0.001 GBP 0 → 13,535

Sign up free to see when this investor has bought or sold shares.

+11 more changes

Sign up

Articles (3)